Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |